FDA, recalls
Digest more
The Food and Drug Administration recalled hundreds of thousands of bottles of the cholesterol drug Atorvastatin Calcium Tablets. The FDA said that nearly 142,000 bottles were recalled because of failed dissolution specifications, meaning the medication did not dissolve as it should have, and may not work as effectively, Fox Business explained.
The U.S. Food and Drug Administration recalled more than 140,000 bottles of a common statin medication. Is your medication one of them?
Over 140,000 bottles of atorvastatin calcium tablets—the generic version of Lipitor—were pulled from shelves across all 50 U.S. states beginning September 19, 2025, after routine quality checks revealed a critical problem: the tablets failed dissolution tests,
More than 3,000 bottles of the popular pain reliever have been pulled from shelves over a packaging defect. The FDA has given the recall the second-highest risk level.
Ascend Laboratories of New Jersey recalled certain bottles of atorvastatin calcium tablets, a generic version of Lipitor, sold nationwide. The drug works to lower cholesterol by blocking an enzyme that helps make cholesterol in the body. The recall affected bottles of 10 milligram (mg), 40 mg, 20 mg, and 80 mg tablets with various pill counts.
The Cool Down on MSN
FDA issues significant recall for several Coca-Cola products — here's what you need to know
This was not the first time Coca-Cola products had to be recalled for a similar reason. FDA issues significant recall for several Coca-Cola products — here's what you need to know first appeared on The Cool Down.
Health on MSN
FDA Announces Nationwide Recall of Peaches Sold at Walmart, Trader Joe’s, and Other Major Retailers
A nationwide recall has been issued for peaches sold at major retailers, including Walmart, Kroger, and Trader Joe's.The peaches, produced by Moonlight Companies, may be contaminated with Listeria, bacteria that can cause serious foodborne illness.
This recall affects America’s most prescribed drug. It’s the latest in a series of concerning manufacturing issues that have come to light over the past few years.